GUIDELINES

← Back to document page

GUIDELINESVersion 2019EnglishGUIDELINESVersion 2021EnglishEACS EuropeanAIDS Clinical Society1EACS GUIDELINES of Contents Introduction to EACS GUIDELINES 20213Summary of Changes from to Members5Governing Board Members5Abbreviations6Part IAssessment of PLWH at Initial & Subsequent Visits7Part IIART of PLWH10Assessing PLWH's Readiness to Start and Maintain ART 10Recommendations for Initiation of ART in PLWH with Chronic Infection without prior ART exposure 12Initial Combination Regimen for ART-na ve Adult PLWH 13Primary HIV Infection (PHI)15Switch Strategies for Virologically Suppressed Persons16Virological Failure17Treatment of Pregnant Women Living with HIV or Women Considering Pregnancy18ART in TB/HIV Co-infection20Post- exposure prophylaxis (PEP) 22Pre- exposure prophylaxis (PrEP)23Adverse Effects of ARVs and Drug Classes 24Part IIIDrug-drug Interactions and Other Prescribing Issues in PLWH26Drug-drug Interactions between ARVs and Non-ARVs27Drug-drug Interactions between Analgesics and ARVs29Drug-drug Interactions between Anticoagulants/Antiplatelet Agents and ARVs30Drug-drug Interactions between Antidepressants and ARVs31Drug-drug Interactions between Antihypertensives and ARVs32Drug-drug Interactions between Anti-malarial Drugs a

Primary HIV Infection (PHI) 15 Switch Strategies for Virologically Suppressed Persons 16 Virological Failure 17 Treatment of Pregnant Women Living with HIV or Women Considering Pregnancy 18 ART in TB/HIV Co-infection 20 Post-exposure Prophylaxis (PEP) 22 Pre-exposure Prophylaxis (PrEP) 23 Adverse Effects of ARVs and Drug Classes 24 Part III

  Guidelines, Post, Exposure, Prophylaxis, Exposure prophylaxis